Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)
China flag China · Delayed Price · Currency is CNY
19.10
-0.63 (-3.19%)
Jul 15, 2025, 10:44 AM CST

SHA:688553 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
8,3586,4396,4096,60414,246-
Upgrade
Market Cap Growth
16.75%0.46%-2.95%-53.64%--
Upgrade
Enterprise Value
6,0184,3954,0063,90113,644-
Upgrade
Last Close Price
19.7314.8014.5014.7331.48-
Upgrade
PE Ratio
33.0119.7945.8526.5231.95-
Upgrade
PS Ratio
7.665.886.914.427.81-
Upgrade
PB Ratio
2.121.621.701.784.00-
Upgrade
P/TBV Ratio
2.151.641.731.814.08-
Upgrade
P/FCF Ratio
66.3556.10--1103.46-
Upgrade
P/OCF Ratio
36.0126.5095.7534.0331.92-
Upgrade
EV/Sales Ratio
5.524.024.322.617.48-
Upgrade
EV/EBITDA Ratio
39.1631.9761.4521.1629.10-
Upgrade
EV/EBIT Ratio
85.7072.08627.1628.5431.47-
Upgrade
EV/FCF Ratio
47.7738.30--1056.83-
Upgrade
Debt / Equity Ratio
0.100.150.110.020.01-
Upgrade
Debt / EBITDA Ratio
2.684.226.140.290.04-
Upgrade
Debt / FCF Ratio
3.275.15--1.55-
Upgrade
Asset Turnover
0.220.220.210.360.681.32
Upgrade
Inventory Turnover
1.011.200.831.051.171.67
Upgrade
Quick Ratio
3.052.783.075.076.111.62
Upgrade
Current Ratio
3.412.943.265.466.561.92
Upgrade
Return on Equity (ROE)
6.29%8.15%3.72%6.84%20.69%58.93%
Upgrade
Return on Assets (ROA)
0.90%0.77%0.09%2.03%10.14%22.78%
Upgrade
Return on Capital (ROIC)
1.00%0.87%0.10%2.32%12.51%39.34%
Upgrade
Return on Capital Employed (ROCE)
1.70%1.50%0.20%3.60%11.90%46.30%
Upgrade
Earnings Yield
3.03%5.05%2.18%3.77%3.13%-
Upgrade
FCF Yield
1.51%1.78%-3.58%-4.05%0.09%-
Upgrade
Dividend Yield
2.31%3.13%1.47%1.60%0.67%-
Upgrade
Payout Ratio
38.54%30.16%70.19%36.21%0.15%0.55%
Upgrade
Buyback Yield / Dilution
-0.32%0.24%-0.37%-13.58%-2.81%-
Upgrade
Total Shareholder Return
1.99%3.37%1.10%-11.99%-2.14%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.